HTAi 2024 Annual Meeting

This year’s Health Technology Assessment International (HTAi) Annual Meeting is held virtually and in person in Seville, Spain. It will gather global leaders for dynamic discussions about the role of HTA in leading health innovation.

Nicole Mittmann, Chief Scientist and Vice-President of Scientific Evidence, Methodologies and Resources; Peter Dyrda, Interim Director of Pharmaceutical Reviews; and Farah Husein, Director of Science and Methods, from Canada's Drug Agency will be participating in various panels, sessions, and workshops at the event. Their participation is noted below (all times in CET):

Saturday, June 15

Peter Dyrda — Workshop 8 (9:00 a.m. to 12:30 p.m.): Assessing The Impact Of HTA As A Cornerstone Of Sustainable Health Systems

Nicole Mittmann — Workshop 10 (1:30 p.m. to 5:00 p.m.): Operationalizing Life Cycle Approaches in HTA

Monday, June 17

Peter Dyrda and Nicole Mittmann — Panel Session 3 (11:35 a.m. to 12:50 p.m.): Trialing Innovative Approaches To Modernize Drug Reviews For Sustainable HTA & Health Systems

Farah Husein (Session Chair) — Presentations 5 (12:55 p.m. to 1:25 p.m.): Health Economics: Payments And Pricing

Nicole Mittmann (Session Co-Chair)— Presentations 11 (3:55 – 4:55 CET): Advancing Evidence: From Trials To Technology Assessments

Learn more about the HTAi 2024 Annual Meeting.